Rotavirus vaccine trivalent - Lanzhou Institute of Biological ProductsAlternative Names: Trivalent genetic reassortant rotavirus vaccine - Lanzhou Institute of Biological Products
Latest Information Update: 25 Nov 2015
At a glance
- Originator Lanzhou Institute of Biological Products
- Class Rotavirus vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Rotavirus infections
Most Recent Events
- 25 Nov 2015 Clinical trials in Rotavirus infections (Prevention) in China (PO)